Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial.
Vanrenterghem Y, van Hooff JP, Squifflet JP, Salmela K, Rigotti P, Jindal RM, Pascual J, Ekberg H, Sicilia LS, Boletis JN, Grinyo JM, Rodriguez MA; European Tacrolimus/MMF Renal Transplantation Study Group. Vanrenterghem Y, et al. Among authors: pascual j. Am J Transplant. 2005 Jan;5(1):87-95. doi: 10.1111/j.1600-6143.2004.00638.x. Am J Transplant. 2005. PMID: 15636615 Free article. Clinical Trial.
Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.
Pascual J, Segoloni G, Gonzalez Molina M, del Castillo D, Capdevila L, Arias M, Garcia J, Ortuño J; Spanish-Italian Tacrolimus Study Group. Pascual J, et al. Transplant Proc. 2003 Aug;35(5):1701-3. doi: 10.1016/s0041-1345(03)00608-0. Transplant Proc. 2003. PMID: 12962764 Clinical Trial.
Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies.
Vitko S, Tedesco H, Eris J, Pascual J, Whelchel J, Magee JC, Campbell S, Civati G, Bourbigot B, Alves Filho G, Leone J, Garcia VD, Rigotti P, Esmeraldo R, Cambi V, Haas T, Jappe A, Bernhardt P, Geissler J, Cretin N. Vitko S, et al. Among authors: pascual j. Am J Transplant. 2004 Apr;4(4):626-35. doi: 10.1111/j.1600-6143.2004.00389.x. Am J Transplant. 2004. PMID: 15023156 Free article. Clinical Trial.
Renal function: defining long-term success.
Pascual J, Marcén R, Ortuño J. Pascual J, et al. Nephrol Dial Transplant. 2004 Dec;19 Suppl 6:vi3-vi7. doi: 10.1093/ndt/gfh1062. Nephrol Dial Transplant. 2004. PMID: 15575023 Review.
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients.
Tedesco-Silva H Jr, Vitko S, Pascual J, Eris J, Magee JC, Whelchel J, Civati G, Campbell S, Alves-Filho G, Bourbigot B, Garcia VD, Leone J, Esmeraldo R, Rigotti P, Cambi V, Haas T; 2306 and 2307 study groups. Tedesco-Silva H Jr, et al. Among authors: pascual j. Transpl Int. 2007 Jan;20(1):27-36. doi: 10.1111/j.1432-2277.2006.00414.x. Transpl Int. 2007. PMID: 17181650 Free article. Clinical Trial.
2,345 results